Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Follicular | 3 | 2019 | 435 | 0.650 |
Why?
|
Physician-Patient Relations | 3 | 2020 | 3217 | 0.630 |
Why?
|
Health Expenditures | 4 | 2020 | 2348 | 0.520 |
Why?
|
Preventive Health Services | 1 | 2019 | 576 | 0.470 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3323 | 0.330 |
Why?
|
Communication | 2 | 2020 | 3722 | 0.330 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2019 | 1373 | 0.290 |
Why?
|
SEER Program | 5 | 2019 | 1506 | 0.290 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5462 | 0.280 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3051 | 0.250 |
Why?
|
Neoplasms | 6 | 2020 | 21507 | 0.250 |
Why?
|
Quality of Health Care | 1 | 2019 | 4365 | 0.230 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7274 | 0.200 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5272 | 0.190 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6361 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11699 | 0.170 |
Why?
|
Medical Oncology | 2 | 2020 | 2217 | 0.150 |
Why?
|
Financing, Personal | 1 | 2020 | 310 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 11410 | 0.150 |
Why?
|
Insurance, Health | 2 | 2020 | 2491 | 0.150 |
Why?
|
Prognosis | 6 | 2019 | 28901 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20055 | 0.130 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1066 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2019 | 12985 | 0.120 |
Why?
|
Exosomes | 1 | 2018 | 412 | 0.120 |
Why?
|
Patient Care Planning | 1 | 2019 | 918 | 0.120 |
Why?
|
Remission Induction | 1 | 2019 | 2378 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 858 | 0.110 |
Why?
|
Shock, Septic | 1 | 2019 | 764 | 0.110 |
Why?
|
United States | 11 | 2023 | 69573 | 0.110 |
Why?
|
Cost of Illness | 2 | 2020 | 1849 | 0.110 |
Why?
|
Aorta | 1 | 2019 | 2048 | 0.100 |
Why?
|
Vincristine | 3 | 2019 | 1038 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 2861 | 0.100 |
Why?
|
Information Dissemination | 1 | 2019 | 1106 | 0.100 |
Why?
|
Cell Communication | 1 | 2018 | 1618 | 0.090 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1909 | 0.090 |
Why?
|
Survivors | 1 | 2020 | 2280 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2019 | 57650 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6516 | 0.090 |
Why?
|
Prednisone | 3 | 2019 | 1560 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12328 | 0.080 |
Why?
|
Comorbidity | 3 | 2019 | 10362 | 0.080 |
Why?
|
Insulin | 1 | 2023 | 6569 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2026 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 3908 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2019 | 1891 | 0.080 |
Why?
|
Medication Adherence | 1 | 2019 | 2047 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3817 | 0.080 |
Why?
|
Cyclophosphamide | 3 | 2019 | 2238 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2019 | 3799 | 0.070 |
Why?
|
Doxorubicin | 3 | 2019 | 2218 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3226 | 0.070 |
Why?
|
Humans | 21 | 2023 | 739398 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3609 | 0.070 |
Why?
|
Medicare | 3 | 2019 | 6497 | 0.070 |
Why?
|
Macrophages, Alveolar | 2 | 2018 | 409 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2629 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2116 | 0.070 |
Why?
|
Sepsis | 1 | 2019 | 2571 | 0.070 |
Why?
|
Aged | 9 | 2020 | 162698 | 0.060 |
Why?
|
Adult | 8 | 2023 | 213394 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5652 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3730 | 0.060 |
Why?
|
Male | 14 | 2020 | 349022 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8039 | 0.060 |
Why?
|
Female | 14 | 2020 | 378853 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 56255 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4426 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9609 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2016 | 10961 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 5950 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 38942 | 0.050 |
Why?
|
Survival Analysis | 3 | 2019 | 10247 | 0.050 |
Why?
|
Therapeutic Equipoise | 1 | 2019 | 28 | 0.040 |
Why?
|
Lung | 1 | 2018 | 9782 | 0.040 |
Why?
|
Medical Savings Accounts | 1 | 2019 | 32 | 0.040 |
Why?
|
Adolescent | 4 | 2020 | 85405 | 0.040 |
Why?
|
Middle Aged | 7 | 2020 | 212863 | 0.040 |
Why?
|
Vital Capacity | 1 | 2019 | 922 | 0.040 |
Why?
|
Deductibles and Coinsurance | 1 | 2019 | 315 | 0.040 |
Why?
|
Drug Substitution | 1 | 2019 | 283 | 0.040 |
Why?
|
Sjogren's Syndrome | 1 | 2017 | 229 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 431 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10793 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 591 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 558 | 0.030 |
Why?
|
Resuscitation | 1 | 2019 | 656 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1740 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2247 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2019 | 423 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 925 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2118 | 0.030 |
Why?
|
Lung Injury | 1 | 2018 | 423 | 0.030 |
Why?
|
Disease Progression | 2 | 2019 | 13237 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 694 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2448 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1778 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2208 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18349 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3498 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3441 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2220 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 4941 | 0.020 |
Why?
|
Pneumonia | 1 | 2018 | 2102 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2091 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6237 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7726 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10398 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13402 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6871 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2018 | 19220 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3712 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 40389 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2017 | 3689 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21694 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15511 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21863 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10534 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40050 | 0.010 |
Why?
|
Animals | 2 | 2018 | 168368 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23355 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81002 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53037 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 76631 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 62693 | 0.010 |
Why?
|
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_